Global /Hong Kong /Healthcare /Drug Manufacturers - General /575
chevron_leftBack
Regent Pacific Group Ltd. logo

Regent Pacific Group Ltd.

575
SHEK: 575 Delayed
0.6200HKD 3.3%
0.0791 USD
As of 6 June 2026, Regent Pacific Group Ltd. has a market cap of $22.35M USD, ranking #36339 globally and #1019 in Hong Kong. It ranks #3264 in the Healthcare sector, and #1093 in the Drug Manufacturers - General industry.
Global Rank
36339
Country Rank
1019
Sector Rank
3264
Industry Rank
1093
Key Stats
Market Cap
$22.35MUSD
175.09M HKD
Enterprise Value
$26.1MUSD
204.53M HKD
Revenue (TTM)
$360.6KUSD
2.83M HKD
EBITDA (TTM)
-$4.26MUSD
-33.38M HKD
Net Income (TTM)
-$4.68MUSD
-36.66M HKD
PS Ratio
62.0
PB Ratio
-3.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jamie Alexander Gibson open_in_new
Employees
16
Founded
1991
Website
regentpac.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.3% -1.6% -23% -37% -6.1% -37%

News

Loading...

Markets

Exchange Ticker Price
Hong Kong Stock Exchange
MIC: XHKG
PRIMARY
575
勵晶太平洋集團有限公司
ISIN: KYG3042R1314
Shares Out.:
291.816M1 Shares Float: 259.44M2
TV:
SA:
YF:
GF:
BA:
575
MS:
0.6200 HKD
Hong Kong Stock Exchange
MIC: XHKG
0575
ISIN: KYG3042R1074
TV:
SA:
YF:
GF:
BA:
MS:
0.4450 HKD
OTC Markets
MIC: OTCM
RPGLF
勵晶太平洋集團有限公司
ISIN: KYG3042R1314
TV:
SA:
YF:
GF:
BA:
MS:
0.1010 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Regent Pacific Group Ltd.

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was founded in 1991 and is headquartered in Central, Hong Kong.

Similar Companies

Industry: Drug Manufacturers - General (Hong Kong)
Name
Market Cap diff.
PE
$14.32B
64K%
-
$12.45B
97.51B HKD
56K%
37.8
$4.7B
36.81B HKD
21K%
-
$4.2B
32.92B HKD
19K%
7.3
$2.86B
22.45B HKD
13K%
18.1
$2.4B
18.78B HKD
11K%
7.7
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
3M%
38.1
JNJ
$547.28B
2M%
26.4
ABBV
$360.63B
2M%
97.4
$324.68B
256.25B CHF
1M%
19.9
AZN
$289.43B
215.59B GBP
1M%
27.6
NOVN
$277.35B
218.9B CHF
1M%
20.5
chevron_leftBack